ArticleBrain communications2026

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.

Thomas Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.